Sandoz Breaks Off Digital Deal With Pear

Decision Follows Change In Sandoz Leadership

Pear
Pear will market the prescription digital therapeutics alone • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business